Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy. - Wikidata - wikimedia - TriplyDB

Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.

Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q37385321

about

Expanding the indications for MRI in the diagnosis and treatment of breast cancer: what is best practice?Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients Primary study of lymph node metastasis-related serum biomarkers in breast cancer.The validity of MRI in evaluation of tumor response to neoadjuvant chemotherapy in locally advanced breast cancer.Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancer Early prediction of response to neoadjuvant chemotherapy for locally advanced breast cancer using MRI Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy.MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.

P2860

Q26801072-38B8BD71-6FE2-416E-9D54-CC23FBDF16CF Q27027281-21C3A95A-51BF-46B8-8C82-E686A43439A3 Q30401252-252B3A75-94D0-4BE6-B6EF-1A91A90347C1 Q33847261-2F6D8BD5-4405-47AD-841E-9ABD1D6F5086 Q34037335-6CC4F78F-0687-4B60-85DA-B5B881075EE1 Q34082321-97060349-4791-4BE1-8A04-C2BC0AA5BB19 Q35207932-0F16D22B-23F3-4FB9-BC71-6AD924EE3722 Q36540092-9AAF3A30-BD1B-4F61-BA42-AF3015D423CE Q36797054-69CC2992-B50D-4372-A672-526E3BBE2548 Q36868191-AB218F90-6B8F-4646-A7D6-C8E2AAC8B18D Q37385251-2FFF6E93-CE50-454B-9073-29FF55D11DB0 Q37938793-2F4A10D3-1A00-47F7-BD5A-38076F856E5C Q42457602-86ED8C60-D56A-4F34-B0B2-BDB9AB64AF01 Q45023166-F0522012-0201-4033-9143-34CA9A97FBF1 Q46088835-81358F90-E507-44BC-98B5-D190FD9A293E Q51005907-DF0E27DC-F7A5-47E4-BA40-C5F933A56561 Q51407617-4C6ACE4D-0DD9-4931-AFD9-538A6177CC61 Q53245198-765587BD-A31C-4E86-A6D0-47129A59EE03

P2860

Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q37385321

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Accuracy of clinical evaluatio ...... ving neoadjuvant chemotherapy.

@en

Accuracy of clinical evaluatio ...... ving neoadjuvant chemotherapy.

@nl

type

label

Accuracy of clinical evaluatio ...... ving neoadjuvant chemotherapy.

@en

Accuracy of clinical evaluatio ...... ving neoadjuvant chemotherapy.

@nl

prefLabel

Accuracy of clinical evaluatio ...... ving neoadjuvant chemotherapy.

@en

Accuracy of clinical evaluatio ...... ving neoadjuvant chemotherapy.

@nl

P1433

Q37385321-6F0FFE83-0EE5-4AE3-8C28-F679C33396FC

P1476

Q37385321-6DAF4650-D714-49C8-8EEE-4661BA4DB3BD

P2093

Q37385321-0BDEEA40-4405-4C48-960E-BD12325E1FE0

Q37385321-1CF08C6F-FF60-48FF-B705-717647A99BA7

Q37385321-79A1540D-7D95-4429-BCF7-E278503B5EFC

Q37385321-CCE37089-2184-4B7B-8045-FDC917D82883

Q37385321-ED32C772-D443-4E8F-8244-41E1BD058E6B

Q37385321-FCA1B1AB-349A-4366-951B-27BE744FECDE

P2860

Q37385321-139C98E6-2D4E-4737-A2F8-81D67525C6FF

Q37385321-21DD7022-6CAC-4729-AC3F-CFBF19F88318

Q37385321-299EC066-8C0E-4DE6-98EB-29593EA21EA9

Q37385321-2C8BF160-76C3-4187-BFED-0A41AA606287

Q37385321-4440AE22-1A4C-41C0-BFCB-B7B2F3BCCD3A

Q37385321-78532A9E-A50B-40E3-A29E-D64253BBCD48

Q37385321-826ED89B-E843-46A8-8839-3E934226D2A3

Q37385321-A65AD2F3-C7E2-48F4-BB89-9D7C237364FE

Q37385321-B3014EF6-F44C-447A-B327-3372821C0045

Q37385321-BCB726A8-6B4D-439F-A539-15F857651FE5

P304

Q37385321-0ACA8546-F917-44FD-A770-E096310593BC

P31

Q37385321-23B2A3EE-AF55-425A-813B-1AA4521F6705

P356

Q37385321-C37E0C3D-B669-4203-A745-F6B1CA41AE0E

P407

Q37385321-4C46CF00-9757-4FD6-92A3-B3FE9D3CD7C8

P433

Q37385321-C48221F5-DCAF-4B73-AEA8-E392FFA7DF64

P478

Q37385321-57E15962-497B-4F4A-B803-A790599F4A6F

P577

Q37385321-68D8C873-BCBE-4183-B67B-F8CF8806FFD7

P5875

Q37385321-EBC06F66-1891-4449-9D7E-0EBBF6EE087D

P698

Q37385321-8E485073-99AB-4920-8B85-24BD5835B7CD

P921

Q37385321-EF66E36D-75BD-4933-AC06-148FC79399C4

P932

Q37385321-9855BB11-745C-46B3-93A7-251A24A3B92E

P356

P1433

P1476

Accuracy of clinical evaluatio ...... ving neoadjuvant chemotherapy.

@en

P2093

Christina A Minami

http://www.w3.org/2001/XMLSchema#string

Debbie Chung

http://www.w3.org/2001/XMLSchema#string

Helena R Chang

http://www.w3.org/2001/XMLSchema#string

Jeff A Gornbein

http://www.w3.org/2001/XMLSchema#string

Nanette Debruhl

http://www.w3.org/2001/XMLSchema#string

Raquel Prati

http://www.w3.org/2001/XMLSchema#string

P2860

Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapy.

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.

Positron emission tomography in the staging and management of breast cancer.

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.

Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.

Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy.

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.

P304

1194-1202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24154

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23804752

http://www.w3.org/2001/XMLSchema#string

P698

19156919

http://www.w3.org/2001/XMLSchema#string

P921

P932

2761029

http://www.w3.org/2001/XMLSchema#string